These results suggest that HK could ameliorate lipotoxicity in hepatocytes by activating SIRT3-AMPK-lipophagy axis, which might be a potential therapeutic agent against NAFLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.